Pathogenesis of Uric Acid Nephrolithiasis: Role of Pioglitazone/Weight Loss

NCT04370093 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Nephrolithiasis, Uric Acid

Interventions

DRUG: Pioglitazone 45 mg
BEHAVIORAL: Weight Loss
OTHER: Pioglitazone + Weight Loss

Sponsor

University of Texas Southwestern Medical Center